Allergy & Immunology CE Activities

ALLERGY & iMMUNOLOGY blog

View Details

6 Ways to Personalize Your Patient’s Asthma Treatment Plan

Asthma management is increasingly becoming more personalized. Here are 6 ways you can help personalize treatment for your patients with asthma that is severe or difficult to control.
View Details

Try These Diets for Your Patients with EoE

In infancy, you can see feeding problems, and as the child progresses to adulthood, you will see them complain about vomiting, abdominal pain, difficulty swallowing, food impaction, and all of this may cause them to avoid eating certain foods, eat very slowly, or avoid social situations where food is involved.

RMEI Presentations

LATEST ALLERGY & IMMUNOLOGY ARTICLES

RSS Latest Allergy & Immunology Articles
  • Multicentric Reticulohistiocytosis June 15, 2024
    A 32-year-old man presented with a 7-year history of skin nodules and swelling, pain, and morning stiffness in his fingers and knuckles, along with smooth nodules over the chest, ears, and fingertips.
    Fei Sun, Jie Zhang
  • Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks May 31, 2024
    In this trial involving 264 hereditary angioedema attacks, oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and complete attack resolution than placebo.
    Marc A. Riedl, Henriette Farkas, Emel Aygören-Pürsün, Fotis Psarros, Daniel F. Soteres, Maria Staevska, Mauro Cancian, David Hagin, Daisuke Honda, Isaac Melamed, Sinisa Savic, Marcin Stobiecki, Paula J. Busse, Eunice Dias de Castro, Nancy Agmon-Levin, Richard Gower, Aharon Kessel, Marcin Kurowski, Ramon Lleonart, Vesna Grivcheva Panovska, H. James Wedner, Paul K. Audhya, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, William R. Lumry, Andrea Zanichelli, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn, the KONFIDENT Investigators*
  • New Therapies for Type 1 and Type 2 Hereditary Angioedema May 31, 2024
    Hereditary angioedema is a rare disorder characterized by recurrent episodes of mucosal swelling. The disease is usually caused by autosomal dominant mutations in SERPING1 , which encodes C1 inhibitor. Type 1 hereditary angioedema is caused by deficiency of C1 inhibitor, whereas type 2 hereditary angioedema is due to dysfunction...
    Rohan Ameratunga, Hilary J. Longhurst

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.